2021 PRiME Fellows Announced

PRiME Fellows represent the next generation of scientific leaders, poised to tackle some of the biggest challenges in health and disease. The 2021 cohort combine expertise across the four PRiME Faculties, applying molecular biology, genomics, computational biology, and bioengineering toward diagnostic and therapeutic solutions.

This year, PRiME Fellows are spearheading projects in screening for drugs against cancers and pathogens, building preclinical tools to model tissue dynamics, and designing nanotechnology and diagnostics for disease.

The 2021 cohort: Dustin Duncan (Cowen & Batey), Emily Gilbert (Morshead & Shoichet), Ingrid Grozavu (Stagljar & Ohh), Yechen Hu (Wheeler & Gilbert), Shahrzad Jahanshahi (Houry & Cochrane), Rick Lu (Radisic & Sefton), Zhen Qin (Liu & Pardee), Tudor Radu (Gunning & Prosser), Wendy Wang (Chou & Allen), and Nila Wu (McGuigan & Arrowsmith) — spanning fungal respiration, multiple sclerosis, KRAS inhibitors, muscle disease, anti-coronavirus therapeutics, COVID-19 heart failure, point-of-care viral detection, liver cancer, tumour immune targeting, and engineered tumour models.